Trial Title:
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
NCT ID:
NCT05976763
Condition:
Mantle Cell Lymphoma
Conditions: Official terms:
Lymphoma
Lymphoma, Mantle-Cell
Rituximab
Zanubrutinib
Fluorodeoxyglucose F18
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Drug
Intervention name:
Zanubrutinib
Description:
Given PO
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Biological
Intervention name:
Rituximab
Description:
Given IV
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Other
Intervention name:
Patient Observation
Description:
Undergo observation
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Procedure
Intervention name:
Bone Marrow Biopsy
Description:
undergo bone marrow biopsy
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Other
Intervention name:
Fludeoxyglucose F-18
Description:
Given IV
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Procedure
Intervention name:
Positron Emission Tomography
Description:
Undergo PET
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Other name:
PET
Intervention type:
Procedure
Intervention name:
Computed Tomography
Description:
Undergo CT
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Other name:
CAT Scan
Other name:
CT Scan
Intervention type:
Procedure
Intervention name:
Magnetic Resonance Imaging
Description:
Undergo MRI
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Other name:
MRI
Intervention type:
Procedure
Intervention name:
Esophagogastroduodenoscopy
Description:
Undergo EGD
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Other name:
EGD
Intervention type:
Procedure
Intervention name:
Colonoscopy
Description:
Undergo colonoscopy
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Procedure
Intervention name:
Biospecimen Collection
Description:
Undergo blood sample collection
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Ancillary studies
Arm group label:
ARM B (Observation)
Arm group label:
Arm A (Zanubrutinib)
Arm group label:
Induction therapy (Zanubrutinib, rituximab)
Summary:
This phase III trial tests whether continuous or intermittent zanubrutinib after
achieving a complete remission (CR) with rituximab works in older adult patients with
mantle cell lymphoma (MCL) who have not received treatment in the past (previously
untreated). Rituximab is a monoclonal antibody that may interfere with the ability of
cancer cells to grow and spread. Zanubrutinib may stop the growth of cancer cells by
blocking some of the enzymes needed for cell growth. When zanubrutinib is used in MCL,
the current standard of care is to continue administering the drug indefinitely until
disease progression. This continuous treatment comes with clinical as well as financial
toxicity, which could be especially detrimental in older patients. For patients who
achieve a CR after initial zanubrutinib plus rituximab therapy, it may be safe and
equally effective to stop treatment and restart zanubrutinib upon disease progression
rather than continuing indefinitely in previously untreated older adult patients with
MCL.
Detailed description:
PRIMARY OBJECTIVE:
I. To compare time to first progression or death (progression free survival [PFS]1) with
continuous treatment (Arm A) and time to second progression or death (PFS2) with
intermittent treatment that is restarted at first progression (Arm B).
KEY SECONDARY OBJECTIVE:
I. To compare overall survival between patients who achieve a complete remission (CR)
with induction therapy subsequently treated with continuous treatment versus (vs.)
intermittent treatment as part of maintenance therapy.
SECONDARY OBJECTIVES:
I. To determine overall response rate (ORR) and CR rate to induction therapy with
zanubrutinib and rituximab in previously untreated MCL.
II. To determine adverse events during induction and post-induction in each study arm
(Arm A and B) by Common Terminology Criteria for Adverse Events (CTCAE) 5.0.
III. To determine PFS1, event free survival (EFS) and overall survival (OS) in each study
arm (A and B).
IV. To determine the overall response rate (ORR) and complete response rate (CR) after
restarting zanubrutinib, following the first progression, in the intermittent treatment
arm (Arm B).
V. To compare burden of symptomatic adverse events (AEs) as assessed by Patient-Reported
Outcome Common Terminology Criteria for Adverse Events (PRO-CTCAE) between patients
randomized to Arm A versus Arm B.
QUALITY OF LIFE PRIMARY OBJECTIVE:
I. To compare health-related quality of life (QOL) at 12 cycles post-randomization as
assessed by the Functional Assessment of Cancer Therapy (FACT) Lymphoma Symptom Index-18
(FLYMSI-18) total score between patients randomized to Arm A versus Arm B.
QUALITY OF LIFE SECONDARY OBJECTIVES:
I. To compare health-related QOL at other time points as assessed by the FLYMSI-18 total
score between patients randomized to Arm A versus Arm B.
II. To compare burden of symptomatic AEs as assessed by PRO-CTCAE between patients
randomized to continuous (Arm A) versus intermittent (Arm B) zanubrutinib treatment.
QUALITY OF LIFE EXPLORATORY OBJECTIVES:
I. To compare the geriatric functional and cognitive PRO as assessed by Elderly
Functional Index (EFLI) and Neurology (Neuro) QOL in Arm A versus Arm B.
II. To compare cognitive function at various time points as assessed by the Neuro-QOL
between patients randomized to continuous (Arm A) versus intermittent (Arm B)
zanubrutinib treatment.
EXPLORATORY OBJECTIVES:
I. To evaluate the completion rate of a lymphoma-specific patient assessment of life
survey (PALS) with patient directed questions on life, health, and social determinants of
health (SDH) and assess the impact of the survey collected data on outcomes for all
enrolled patients (study arms A and B).
II. To evaluate minimal residual disease (MRD) in those patients who achieve a CR after
induction therapy (arms A and B) and how detectable MRD status changes after continued
therapy vs. discontinuation of therapy (i.e. arms A vs. B).
OUTLINE:
INDUCTION THERAPY: Patients receive zanubrutinib orally (PO) and rituximab intravenously
(IV) on study. Patients undergo bone marrow biopsy and fluciclovine F18 (FDG) positron
emission tomography (PET)/ computed tomography (CT) or CT throughout the trial. Patients
may also undergo esophagogastroduodenoscopy (EGD) and/or colonoscopy on study as
clinically indicated. Patients may optionally undergo blood sample collection throughout
the trial.
MAINTENANCE THERAPY: Patients achieving a CR after induction therapy are randomized to 1
of 2 arms.
ARM A: Patients receive zanubrutinib PO until first disease progression on study.
Patients undergo CT or magnetic resonance imaging (MRI) or FDG PET/CT throughout the
trial. Patients may optionally undergo blood sample collection throughout the trial.
ARM B: Patients undergo observation until first disease progression and then receive
zanubrutinib PO until second disease progression on study. Patients undergo CT or MRI or
FDG PET/CT throughout the trial. Patients may optionally undergo blood sample collection
throughout the trial.
After completion of study treatment, patients are followed within 30 days and every 6
months for 10 years.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- • Histologically confirmed mantle cell lymphoma with cyclin D1 (BCL1) expression by
immunohistochemical stains and/or t(11;14) by cytogenetics or fluorescence in situ
hybridization (FISH) as confirmed by the enrolling center
- Any stage allowed (stage I-IV)
- Presence of measurable disease, defined as >= 1 nodal lesion that is > 1.5
cm in longest diameter or >= 1 extranodal lesion that is > 1 cm in longest
diameter
- Steroids for management of mantle cell lymphoma are allowed up to a dose
of prednisone 100mg/day (or equivalent) for up to 7 days
- No prior systemic treatment for mantle cell lymphoma
- No prior radiation treatment for stage I MCL
- No prior exposure to a BTK inhibitor or anti-CD20 monoclonal antibody
- No prior stem cell transplant
- Age >= 70 years OR age >= 60 to < 70 years with comorbidities precluding
autologous stem cell transplantation (autoSCT) including at least one of
the following: a) cardiac ejection fraction (EF) < 45%, b) diffusing
capacity for carbon monoxide < 60% predicted; c) creatinine clearance < 70
but > 30ml/minute (min); d) Eastern Cooperative Oncology Group (ECOG)
performance status of 2, which poses an unacceptable risk of toxicity for
high-dose therapy and stem cell transplantation; or e) Cumulative Illness
Rating Scales (CIRS) total score > 6
- ECOG Performance Status 0-2
- Absolute neutrophil count (ANC) >= 750/mm^3 (without growth factor support
within 7 days)
- Platelet count >= 75,000/mm^3 (or >= 50,000/mm^3 for patients with bone
marrow involvement of lymphoma) without growth factor support or
transfusion within 7 days
- Creatinine clearance >= 30 mL/ min determined by either: a) Estimation
using the Cockcroft-Gault equation or b) Measurement by nuclear medicine
scan or 24 hour urine collection
- Total bilirubin =< 1.5 x upper limit of normal (ULN) (unless documented
Gilbert's syndrome)
- Aspartate transferase (AST) / alanine transaminase (ALT) =< 3 x ULN
- Patients should not be considered candidates for stem cell transplant or
must have declined a stem cell transplant strategy
- No clinically significant cardiovascular disease including the following
- Unstable angina within 3 months before registration
- New York Heart Association class III or IV congestive heart failure
- History of clinically significant arrhythmias (eg, sustained ventricular
tachycardia, ventricular fibrillation, torsades de pointes)
- QT correction formula (QTcF) > 480 msecs based on Fredericia's formula
- History of Mobitz II second-degree or third-degree heart block without a
permanent pacemaker in place
- Human immunodeficiency virus (HIV)-infected patients on effective
anti-retroviral therapy with undetectable viral load within 6 months are
eligible for this trial
- No active Hepatitis B or Hepatitis C infection. Patients with prior
hepatitis B virus (HBV) exposure (positive HBV core antibody and/or
surface antigen) are eligible if they have no detectable viral load, and
are taking appropriate prophylactic antiviral therapy to prevent
reactivation. Patients with history of hepatitis C virus (HCV) are
eligible if they have an undetectable HCV viral load
- Patients with a prior or concurrent malignancy whose natural history or
treatment does not have the potential to interfere with the safety or
efficacy assessment of the investigational regimen are eligible for this
trial
- No history of severe bleeding disorder such as hemophilia A, hemophilia B,
von Willebrand disease, or history of spontaneous bleeding requiring blood
transfusion or other medical intervention
- No history of stroke or intracranial hemorrhage within 6 months prior to
registration
- No disease significantly affecting gastrointestinal function such as
malabsorption syndrome, resection of the stomach or small bowel, bariatric
surgery procedures, symptomatic inflammatory bowel disease, or partial or
complete bowel obstruction. Patient must be able to swallow pills
- Potential trial participants should have recovered from major surgery
- No vaccination with a live vaccine within 35 days prior to registration
- No hypersensitivity to zanubrutinib or rituximab or any of the other
ingredients of the study drugs
- Chronic concomitant treatment with strong inhibitors of CYP3A4 is not
allowed on this study. Patients on strong CYP3A4 inhibitors must
discontinue the drug for 14 days prior to registration on the study.
- Chronic concomitant treatment with strong CYP3A4 inducers is not allowed.
Patients must discontinue the drug 14 days prior to the start of study
treatment
- Avoid use of moderate CYP3A4 inhibitors, PGP inhibitors, and moderate
CYP3A4 inducers
- Archival tissue must be available for submission in all patients for
histopathology review, though participation in correlative substudies is
optional
Gender:
All
Minimum age:
60 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
City of Hope Comprehensive Cancer Center
Address:
City:
Duarte
Zip:
91010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-826-4673
Email:
becomingapatient@coh.org
Investigator:
Last name:
Tycel J. Phillips
Email:
Principal Investigator
Facility:
Name:
City of Hope at Irvine Lennar
Address:
City:
Irvine
Zip:
92618
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-467-3411
Investigator:
Last name:
Tycel J. Phillips
Email:
Principal Investigator
Facility:
Name:
Cedars Sinai Medical Center
Address:
City:
Los Angeles
Zip:
90048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
310-423-8965
Investigator:
Last name:
Justin M. Darrah
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Derby Care Center
Address:
City:
Derby
Zip:
06418
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Fairfield
Address:
City:
Fairfield
Zip:
06824
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Glastonbury
Address:
City:
Glastonbury
Zip:
06033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Greenwich
Address:
City:
Greenwich
Zip:
06830
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Guilford
Address:
City:
Guilford
Zip:
06437
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Saint Francis
Address:
City:
Hartford
Zip:
06105
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Yale University
Address:
City:
New Haven
Zip:
06520
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Yale-New Haven Hospital North Haven Medical Center
Address:
City:
North Haven
Zip:
06473
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Long Ridge
Address:
City:
Stamford
Zip:
06902
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Torrington Care Center
Address:
City:
Torrington
Zip:
06790
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Trumbull
Address:
City:
Trumbull
Zip:
06611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Waterbury Care Center
Address:
City:
Waterbury
Zip:
06708
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Waterford
Address:
City:
Waterford
Zip:
06385
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Helen F Graham Cancer Center
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Medical Oncology Hematology Consultants PA
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital Midtown
Address:
City:
Atlanta
Zip:
30308
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-946-7447
Investigator:
Last name:
Jonathon B. Cohen
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital/Winship Cancer Institute
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-778-1868
Investigator:
Last name:
Jonathon B. Cohen
Email:
Principal Investigator
Facility:
Name:
Emory Saint Joseph's Hospital
Address:
City:
Atlanta
Zip:
30342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-851-7115
Investigator:
Last name:
Jonathon B. Cohen
Email:
Principal Investigator
Facility:
Name:
Augusta University Medical Center
Address:
City:
Augusta
Zip:
30912
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
706-721-2388
Email:
ga_cares@augusta.edu
Investigator:
Last name:
Locke J. Bryan
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Boise
Address:
City:
Boise
Zip:
83706
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-3671
Email:
stephanie.couch@stjoeshealth.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Caldwell
Address:
City:
Caldwell
Zip:
83605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-3671
Email:
stephanie.couch@stjoeshealth.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Health - Coeur d'Alene
Address:
City:
Coeur d'Alene
Zip:
83814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Nampa
Address:
City:
Nampa
Zip:
83687
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Post Falls
Address:
City:
Post Falls
Zip:
83854
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Sandpoint
Address:
City:
Sandpoint
Zip:
83864
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Bloomington
Address:
City:
Bloomington
Zip:
61704
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Canton
Address:
City:
Canton
Zip:
61520
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Carthage
Address:
City:
Carthage
Zip:
62321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle at The Riverfront
Address:
City:
Danville
Zip:
61832
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@Carle.com
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Cancer Care Specialists of Illinois - Decatur
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Decatur Memorial Hospital
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Dixon
Address:
City:
Dixon
Zip:
61021
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
815-285-7800
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Effingham
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Crossroads Cancer Center
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Eureka
Address:
City:
Eureka
Zip:
61530
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Galesburg
Address:
City:
Galesburg
Zip:
61401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Kewanee Clinic
Address:
City:
Kewanee
Zip:
61443
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Macomb
Address:
City:
Macomb
Zip:
61455
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Mattoon/Charleston
Address:
City:
Mattoon
Zip:
61938
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Cancer Care Center of O'Fallon
Address:
City:
O'Fallon
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Ottawa Clinic
Address:
City:
Ottawa
Zip:
61350
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Pekin
Address:
City:
Pekin
Zip:
61554
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Peoria
Address:
City:
Peoria
Zip:
61615
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Peru
Address:
City:
Peru
Zip:
61354
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Princeton
Address:
City:
Princeton
Zip:
61356
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital East
Address:
City:
Shiloh
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-747-9912
Email:
dschwab@wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
Southern Illinois University School of Medicine
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-545-7929
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Springfield Clinic
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-444-7541
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Memorial Medical Center
Address:
City:
Springfield
Zip:
62781
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-528-7541
Email:
pallante.beth@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Cancer Center
Address:
City:
Urbana
Zip:
61801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare - Washington
Address:
City:
Washington
Zip:
61571
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Main Campus
Address:
City:
Crown Point
Zip:
46307
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-310-2550
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Northwest Oncology LLC
Address:
City:
Dyer
Zip:
46311
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-924-8178
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Hobart
Address:
City:
Hobart
Zip:
46342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-947-1795
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Saint Mary Medical Center
Address:
City:
Hobart
Zip:
46342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-6875
Email:
CancerResearch@COMHS.org
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Saint Catherine Hospital
Address:
City:
Indianapolis
Zip:
46312
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
The Community Hospital
Address:
City:
Munster
Zip:
46321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-3349
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Women's Diagnostic Center - Munster
Address:
City:
Munster
Zip:
46321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-934-8869
Email:
mnicholson@comhs.org
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Valparaiso
Address:
City:
Valparaiso
Zip:
46383
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-6875
Email:
CancerResearch@COMHS.org
Investigator:
Last name:
Maria T. Grosse-Perdekamp
Email:
Principal Investigator
Facility:
Name:
Mary Greeley Medical Center
Address:
City:
Ames
Zip:
50010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Ames
Address:
City:
Ames
Zip:
50010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-239-4734
Email:
ksoder@mcfarlandclinic.com
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Ankeny
Address:
City:
Ankeny
Zip:
50023
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-282-2921
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Boone
Address:
City:
Boone
Zip:
50036
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
Mercy Medical Center - Des Moines
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Trinity Cancer Center
Address:
City:
Fort Dodge
Zip:
50501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
University of Iowa/Holden Comprehensive Cancer Center
Address:
City:
Iowa City
Zip:
52242
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-237-1225
Investigator:
Last name:
Eric Mou
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Jefferson
Address:
City:
Jefferson
Zip:
50129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Marshalltown
Address:
City:
Marshalltown
Zip:
50158
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
HaysMed
Address:
City:
Hays
Zip:
67601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-623-5774
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center
Address:
City:
Kansas City
Zip:
66160
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Lawrence Memorial Hospital
Address:
City:
Lawrence
Zip:
66044
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-505-2800
Email:
Stephanie.Norris@LMH.ORG
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Olathe Health Cancer Center
Address:
City:
Olathe
Zip:
66061
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-355-8000
Email:
Jeni.wakefield@olathehealth.org
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center-Overland Park
Address:
City:
Overland Park
Zip:
66210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Freeman Physician Group of Pittsburg
Address:
City:
Pittsburg
Zip:
66762
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
BNMathew@freemanhealth.com
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Salina Regional Health Center
Address:
City:
Salina
Zip:
67401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-452-7038
Email:
mleepers@srhc.com
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Health System Saint Francis Campus
Address:
City:
Topeka
Zip:
66606
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-295-8000
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Hospital-Westwood Cancer Center
Address:
City:
Westwood
Zip:
66205
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Alliance for Clinical Trials in Oncology
Address:
City:
Boston
Zip:
02115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anne W. Beaven
Email:
beaven@med.unc.edu
Investigator:
Last name:
Anne W. Beaven
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Medical Center - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Medical Center - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Corewell Health Farmington Hills Hospital
Address:
City:
Farmington Hills
Zip:
48336
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Andrew A. Muskovitz
Email:
Principal Investigator
Facility:
Name:
Genesee Cancer and Blood Disease Treatment Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Genesee Hematology Oncology PC
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Genesys Hurley Cancer Institute
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Hurley Medical Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Great Lakes Cancer Management Specialists-Macomb Medical Campus
Address:
City:
Macomb
Zip:
48044
Country:
United States
Status:
Suspended
Facility:
Name:
Corewell Health William Beaumont University Hospital
Address:
City:
Royal Oak
Zip:
48073
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Andrew A. Muskovitz
Email:
Principal Investigator
Facility:
Name:
Corewell Health Beaumont Troy Hospital
Address:
City:
Troy
Zip:
48085
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Andrew A. Muskovitz
Email:
Principal Investigator
Facility:
Name:
Huron Gastroenterology PC
Address:
City:
Ypsilanti
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Address:
City:
Ypsilanti
Zip:
48197
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Sanford Joe Lueken Cancer Center
Address:
City:
Bemidji
Zip:
56601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-333-5000
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Essentia Health Saint Joseph's Medical Center
Address:
City:
Brainerd
Zip:
56401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital
Address:
City:
Coon Rapids
Zip:
55433
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
Essentia Health - Deer River Clinic
Address:
City:
Deer River
Zip:
56636
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Essentia Health Cancer Center
Address:
City:
Duluth
Zip:
55805
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Essentia Health Hibbing Clinic
Address:
City:
Hibbing
Zip:
55746
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Saint John's Hospital - Healtheast
Address:
City:
Maplewood
Zip:
55109
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
Abbott-Northwestern Hospital
Address:
City:
Minneapolis
Zip:
55407
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
Park Nicollet Clinic - Saint Louis Park
Address:
City:
Saint Louis Park
Zip:
55416
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
Regions Hospital
Address:
City:
Saint Paul
Zip:
55101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
United Hospital
Address:
City:
Saint Paul
Zip:
55102
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
Essentia Health Sandstone
Address:
City:
Sandstone
Zip:
55072
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Essentia Health Virginia Clinic
Address:
City:
Virginia
Zip:
55792
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Saint Francis Medical Center
Address:
City:
Cape Girardeau
Zip:
63703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-334-2230
Email:
sfmc@sfmc.net
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Hospital
Address:
City:
Chesterfield
Zip:
63017
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-205-6936
Investigator:
Last name:
Mark J. Fesler
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at West County Hospital
Address:
City:
Creve Coeur
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
University Health Truman Medical Center
Address:
City:
Kansas City
Zip:
64108
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
816-404-4375
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - North
Address:
City:
Kansas City
Zip:
64154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - Lee's Summit
Address:
City:
Lee's Summit
Zip:
64064
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center at North Kansas City Hospital
Address:
City:
North Kansas City
Zip:
64116
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Marc S. Hoffmann
Email:
Principal Investigator
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center-South County
Address:
City:
Saint Louis
Zip:
63129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Christian Hospital
Address:
City:
Saint Louis
Zip:
63136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Saint Peters Hospital
Address:
City:
Saint Peters
Zip:
63376
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Brad S. Kahl
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital Springfield
Address:
City:
Springfield
Zip:
65804
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
417-269-4520
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
CoxHealth South Hospital
Address:
City:
Springfield
Zip:
65807
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
417-269-4520
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
Community Hospital of Anaconda
Address:
City:
Anaconda
Zip:
59711
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Billings Clinic Cancer Center
Address:
City:
Billings
Zip:
59101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-996-2663
Email:
research@billingsclinic.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Bozeman Health Deaconess Hospital
Address:
City:
Bozeman
Zip:
59715
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Benefis Sletten Cancer Institute
Address:
City:
Great Falls
Zip:
59405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kalispell Regional Medical Center
Address:
City:
Kalispell
Zip:
59901
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Community Medical Center
Address:
City:
Missoula
Zip:
59804
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Bellevue
Address:
City:
Bellevue
Zip:
68123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Julie M. Vose
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Village Pointe
Address:
City:
Omaha
Zip:
68118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-5600
Investigator:
Last name:
Julie M. Vose
Email:
Principal Investigator
Facility:
Name:
University of Nebraska Medical Center
Address:
City:
Omaha
Zip:
68198
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Julie M. Vose
Email:
Principal Investigator
Facility:
Name:
Roswell Park Cancer Institute
Address:
City:
Buffalo
Zip:
14263
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-767-9355
Email:
askroswell@roswellpark.org
Investigator:
Last name:
Dorothy C. Pan
Email:
Principal Investigator
Facility:
Name:
Hematology Oncology Associates of Central New York-East Syracuse
Address:
City:
East Syracuse
Zip:
13057
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-472-7504
Investigator:
Last name:
Steven M. Duffy
Email:
Principal Investigator
Facility:
Name:
University of Rochester
Address:
City:
Rochester
Zip:
14642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
585-275-5830
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Wilmot Cancer Institute at Webster
Address:
City:
Webster
Zip:
14580
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
WCICTOresearch@urmc.rochester.edu
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
UNC Lineberger Comprehensive Cancer Center
Address:
City:
Chapel Hill
Zip:
27599
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-668-0683
Email:
cancerclinicaltrials@med.unc.edu
Investigator:
Last name:
Anne W. Beaven
Email:
Principal Investigator
Facility:
Name:
Duke University Medical Center
Address:
City:
Durham
Zip:
27710
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-275-3853
Investigator:
Last name:
Matthew S. McKinney
Email:
Principal Investigator
Facility:
Name:
Sanford Bismarck Medical Center
Address:
City:
Bismarck
Zip:
58501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Essentia Health Cancer Center-South University Clinic
Address:
City:
Fargo
Zip:
58103
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Sanford Broadway Medical Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Roger Maris Cancer Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-234-6161
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Ohio State University Comprehensive Cancer Center
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-293-5066
Email:
Jamesline@osumc.edu
Investigator:
Last name:
David A. Bond
Email:
Principal Investigator
Facility:
Name:
Cancer Centers of Southwest Oklahoma Research
Address:
City:
Lawton
Zip:
73505
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-231-4440
Investigator:
Last name:
Taha Al-Juhaishi
Email:
Principal Investigator
Facility:
Name:
University of Oklahoma Health Sciences Center
Address:
City:
Oklahoma City
Zip:
73104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-271-8777
Email:
ou-clinical-trials@ouhsc.edu
Investigator:
Last name:
Taha Al-Juhaishi
Email:
Principal Investigator
Facility:
Name:
Oklahoma Cancer Specialists and Research Institute-Tulsa
Address:
City:
Tulsa
Zip:
74146
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
918-505-3200
Investigator:
Last name:
Taha Al-Juhaishi
Email:
Principal Investigator
Facility:
Name:
Providence Newberg Medical Center
Address:
City:
Newberg
Zip:
97132
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Ontario
Address:
City:
Ontario
Zip:
97914
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Providence Willamette Falls Medical Center
Address:
City:
Oregon City
Zip:
97045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Providence Portland Medical Center
Address:
City:
Portland
Zip:
97213
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Providence Saint Vincent Medical Center
Address:
City:
Portland
Zip:
97225
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Rhode Island Hospital
Address:
City:
Providence
Zip:
02903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
401-444-1488
Investigator:
Last name:
Adam J. Olszewski
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Westerly
Address:
City:
Westerly
Zip:
02891
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Shalin Kothari
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Spartanburg
Address:
City:
Boiling Springs
Zip:
29316
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Easley
Address:
City:
Easley
Zip:
29640
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-522-2066
Email:
Kim.Williams3@prismahealth.org
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Butternut
Address:
City:
Greenville
Zip:
29605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Faris
Address:
City:
Greenville
Zip:
29605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Eastside
Address:
City:
Greenville
Zip:
29615
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Greer
Address:
City:
Greer
Zip:
29650
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Seneca
Address:
City:
Seneca
Zip:
29672
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Suzanne R. Fanning
Email:
Principal Investigator
Facility:
Name:
Sanford Cancer Center Oncology Clinic
Address:
City:
Sioux Falls
Zip:
57104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicTrialsSF@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford USD Medical Center - Sioux Falls
Address:
City:
Sioux Falls
Zip:
57117-5134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicalTrialsSF@SanfordHealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Huntsman Cancer Institute/University of Utah
Address:
City:
Salt Lake City
Zip:
84112
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-424-2100
Email:
cancerinfo@hci.utah.edu
Investigator:
Last name:
Harsh Shah
Email:
Principal Investigator
Facility:
Name:
VCU Massey Cancer Center at Stony Point
Address:
City:
Richmond
Zip:
23235
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
ctoclinops@vcu.edu
Investigator:
Last name:
Bruce O. Hough
Email:
Principal Investigator
Facility:
Name:
Virginia Commonwealth University/Massey Cancer Center
Address:
City:
Richmond
Zip:
23298
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CTOclinops@vcu.edu
Investigator:
Last name:
Bruce O. Hough
Email:
Principal Investigator
Facility:
Name:
Swedish Cancer Institute-Edmonds
Address:
City:
Edmonds
Zip:
98026
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
206-215-3086
Email:
PCRC-NCORP@Swedish.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Swedish Cancer Institute-Issaquah
Address:
City:
Issaquah
Zip:
98029
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
206-215-3086
Email:
PCRC-NCORP@Swedish.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Swedish Medical Center-First Hill
Address:
City:
Seattle
Zip:
98122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
206-215-3086
Email:
PCRC-NCORP@Swedish.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Duluth Clinic Ashland
Address:
City:
Ashland
Zip:
54806
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Gundersen Lutheran Medical Center
Address:
City:
La Crosse
Zip:
54601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
608-775-2385
Email:
cancerctr@gundersenhealth.org
Investigator:
Last name:
Michael O. Ojelabi
Email:
Principal Investigator
Facility:
Name:
University of Wisconsin Carbone Cancer Center - University Hospital
Address:
City:
Madison
Zip:
53792
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-622-8922
Email:
clinicaltrials@cancer.wisc.edu
Investigator:
Last name:
Priyanka Pophali
Email:
Principal Investigator
Facility:
Name:
Medical College of Wisconsin
Address:
City:
Milwaukee
Zip:
53226
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-805-3666
Investigator:
Last name:
Timothy S. Fenske
Email:
Principal Investigator
Facility:
Name:
ProHealth D N Greenwald Center
Address:
City:
Mukwonago
Zip:
53149
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
research.institute@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
Froedtert and MCW Moorland Reserve Health Center
Address:
City:
New Berlin
Zip:
53151
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-805-0505
Investigator:
Last name:
Timothy S. Fenske
Email:
Principal Investigator
Facility:
Name:
ProHealth Oconomowoc Memorial Hospital
Address:
City:
Oconomowoc
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7878
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
UW Cancer Center at ProHealth Care
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-5539
Email:
Chanda.miller@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Start date:
September 8, 2023
Completion date:
August 31, 2038
Lead sponsor:
Agency:
Alliance for Clinical Trials in Oncology
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Alliance for Clinical Trials in Oncology
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05976763
